Allied Biotech Corporation

TPEX:1780 Voorraadrapport

Marktkapitalisatie: NT$1.6b

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Allied Biotech Beheer

Beheer criteriumcontroles 0/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Qing Hui Lin

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOno data
Eigendom CEO1.0%
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuurgeen gegevens

Recente managementupdates

Recent updates

Is Allied Biotech Corporation (GTSM:1780) A Good Dividend Stock?

Apr 16
Is Allied Biotech Corporation (GTSM:1780) A Good Dividend Stock?

These 4 Measures Indicate That Allied Biotech (GTSM:1780) Is Using Debt Reasonably Well

Mar 05
These 4 Measures Indicate That Allied Biotech (GTSM:1780) Is Using Debt Reasonably Well

Allied Biotech (GTSM:1780) Has Compensated Shareholders With A Respectable 49% Return On Their Investment

Jan 24
Allied Biotech (GTSM:1780) Has Compensated Shareholders With A Respectable 49% Return On Their Investment

Is Allied Biotech Corporation (GTSM:1780) At Risk Of Cutting Its Dividend?

Jan 03
Is Allied Biotech Corporation (GTSM:1780) At Risk Of Cutting Its Dividend?

A Look At The Intrinsic Value Of Allied Biotech Corporation (GTSM:1780)

Dec 13
A Look At The Intrinsic Value Of Allied Biotech Corporation (GTSM:1780)

Is Allied Biotech (GTSM:1780) A Risky Investment?

Nov 25
Is Allied Biotech (GTSM:1780) A Risky Investment?

CEO

Qing Hui Lin

no data

Tenure

Qing Hui Lin is the Chief Executive Officer and Director of Allied Biotech Corporation.